Artisan Bio
Crafting the best cells to make the best cures
Crafting the best cells to make the best cures
Artisan Bio is a biotechnology startup with a compelling slogan – "Crafting the best cells to make the best cures". Established in 2019, the company is dedicated to developing customized cell engineering solutions for complex human health issues. With headquarters in the United States and operational facilities in Denver, Colorado and Toronto, Ontario, Artisan is focused on creating a CRISPR-driven cell therapy foundry. The company recently received a significant investment of $21.00M in a Series A round on 25 November 2020, led by XSeed Capital and Northpond Ventures. Artisan Bio operates at the intersection of biotechnology, healthcare, and information technology, positioning itself as a promising player in the evolving landscape of medical innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $21.00M | 2 |
|
25 Nov 2020 |
No recent news or press coverage available for Artisan Bio.
We care about your data, and we'd love to use cookies make your experience better.
